NEA Management Company, LLC
Annual return '25
+15.2%
SPY '25
+17.7%
Alpha
-2.5ptsvs SPY
Invested
$1.8B
Holdings
27
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 99%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$ACLX
Arcellx, Inc.
Q4 2025: Exited (was 3.05M shares)
19.9%
02
$CELC
Celcuity Inc.
Q4 2025: Exited (was 2.14M shares)
14.8%
03
$SGP
Spyglass Pharma, Inc.
Held since at least Q1 2024
10.9%
04
$TRVI
Trevi Therapeutics, Inc.
Q4 2025: Exited (was 13.22M shares)
9.0%
05
$SVRA
Savara, Inc.
Q4 2025: Exited (was 24.47M shares)
7.6%
06
$GLUE
Monte Rosa Therapeutics, Inc.
Q4 2025: Exited (was 7.69M shares)
7.2%
07
$MBX
MBX Biosciences, Inc.
Q4 2025: Exited (was 3.61M shares)
6.1%
08
$ZBIO
Zenas BioPharma, Inc.
Q4 2025: Exited (was 2.73M shares)
4.5%
09
$COUR
Coursera, Inc.
Q4 2025: Exited (was 12.87M shares)
4.3%
10
$AUPH
Aurinia Pharmaceuticals, Inc.
Q4 2025: Exited (was 3.97M shares)
3.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 09:26 UTC.